chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lingering neck pain; lethargy; fever; chills; nausea; This spontaneous case was reported by a patient and describes the occurrence of NECK PAIN (lingering neck pain), LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NECK PAIN (lingering neck pain). 06-Mar-2021, the patient experienced LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (MORTIN) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 10-Mar-2021, LETHARGY (lethargy), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) had resolved. At the time of the report, NECK PAIN (lingering neck pain) outcome was unknown.            No concomitant medications were reported.   .   This case was linked to US-MODERNATX, INC.-MOD-2021-081356 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081356:1ST DOSE
arm hurt for three days, much worse than a flu shot; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Flu vaccine.     Linked case(s) involving the same patient:  US2022AMR056415   Additional Information: GSK Receipt Date: 25-MAR-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received Flu shot and experienced pain in arm. The patient stated that the Shingles shot was not too much worse than a flu shot. Additional supportive information: The follow-up would not possible, as no contact details were available. This case has been linked to the case US2022AMR056415 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR056415:same reporter
got shingles even though she got the shot/ suspected vaccination failure; Shingles; Sick bad; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and sickness. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the vaccination failure, shingles and sickness were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and sickness to be related to Shingles vaccine.  Additional details were reported as follows: The patient was reporter's mother. The age at vaccination was not reported. The patient got shingles even though she got the Shingles shot and she was sick bad. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of M-M-R II (unknown route and strength) Lot # J013431 with expiry date of 24-OCT-2015. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
On 1/29/2021, 10 days after first vaccine, patient developed severe itch at injection site.  Symptoms also included a large, raised spot around the site.  Itching continued for approx. 24 hours.
The next day the patient became ver sick and progressed to severe abdominal pain, went to the ER diagnosed with Pancreatitis. Patient had no stones and does not drink.
Pt received wrong dose, should have gotten the blue cap Mod bivalent vaccine 0.25ml. Pt will need additional dose.
not feeling great (1st dose); hot flashes (1st dose); dizziness (1st dose); covid-19 symptoms (1st dose); This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling great (1st dose)), HOT FLUSH (hot flashes (1st dose)), DIZZINESS (dizziness (1st dose)) and INFLUENZA LIKE ILLNESS (covid-19 symptoms (1st dose)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (not feeling great (1st dose)), HOT FLUSH (hot flashes (1st dose)), DIZZINESS (dizziness (1st dose)) and INFLUENZA LIKE ILLNESS (covid-19 symptoms (1st dose)). At the time of the report, FEELING ABNORMAL (not feeling great (1st dose)), HOT FLUSH (hot flashes (1st dose)), DIZZINESS (dizziness (1st dose)) and INFLUENZA LIKE ILLNESS (covid-19 symptoms (1st dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       DIAGNOSTIC RESULTS: On an unknown date, SARS-CoV-2 test: Tested negative.  No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-046185 (Patient Link).
States had pneumonia in SEP was hospitalized 1 wk the 1st of OCT; back to work part-time during NOV; MD suggested vax given 3PM @ 630 stated had pain in lt arm by 730 numbness in lt arm moving to chest;
Shooting discomfort in never ends of right side of face and teeth and gums.  Went to doctor's office on 8/3/2012 and was told I had Shingles.  My Shingles Shot adminstered two days previously. Zostavax (NDC: 00006-4963-31) caused my Shingles.
pain in arm; This is a spontaneous report received from a contactable reporter (consumer or other non-healthcare professional) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain in arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 09-SEP-2015 the patient was vaccinated with a dose of improperly stored (Merck) VARIVAX (lot # L003777, expiration date 04-FEB-2017, dose and route were not reported). Concomitant drug was not reported. No adverse reactions were reported. This is one of the two reports from the same reporter. Additional information has been requested.
Patient collapsed to the ground when walking to leave the post vaccine clinic observation area. She collapsed and had a 60second seizure followed by 4 minutes of post ictal activity. She did not vocalize answers during the time but nodded yes when asked if she had a seizure disorder. Patient had another 60 second seizure and then EMS arrived. Her seizure was generalized twitching and patient was unconscious. Vitals remained stable.
Parotid tumor; Left sided Facial droop; This is a spontaneous report received from a contactable other HCP (patient). A 25-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 intramuscular, administered in Arm Left on 01Feb2021 (at 25 years old, not pregnant) as 2ND DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had her first dose of bnt162b2 vaccine on 11Jan2021 on left arm, intramuscular at 25years old for Covid-19 immunization and experienced ear pain. On 18Feb2021, 17 days after second dose, patient experienced left sided Facial droop. Have been seen by ENT and had MRI and CT done along with Biopsy of what appeared to be a parotid tumor however may not be a tumor and further testing will be done. Treatment was given for the events. The outcome of the events was not recovered. The events was assessed as life-threatening. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events occurred in a plausible temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
She experienced some emesis post vaccine, and felt light headed.  A MAT was called after the emesis and she was deemed stable to stay in vaccine clinic for observation and discharge.
severe bone pain; cannot move; muscle pain; This spontaneous case was reported by a health care professional and describes the occurrence of BONE PAIN (severe bone pain), HYPOKINESIA (cannot move) and MYALGIA (muscle pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, METOPROLOL TARTRATE, APIXABAN (ELIQUIS), ROSUVASTATIN and CALCIUM for an unknown indication.    On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced BONE PAIN (severe bone pain), HYPOKINESIA (cannot move) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and tramadol for Pain, at an unspecified dose and frequency. At the time of the report, BONE PAIN (severe bone pain), HYPOKINESIA (cannot move) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
1st dose prior to Covid 19. Can get her 2nd now?; This case was reported by a pharmacist and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date prior to Covid 19 pandemic).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by pharmacist. The age at vaccination was not applicable for this report. The patient had received the 1st dose of Shingrix prior to Covid 19 pandemic. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked if she could get her 2nd dose now or if patient need to restart the series. The reporter consented to follow up.
PT.RECEIVED DAPTCELL 6-2-04.THAT NIGHT MOTHER STATES INJ.SITE BECAMED RED & SLIGHTLY SWOLLEN, WARM TO TOUCH, & ITCHY.PT SEEN IN OFFICE 6-4-04, INJ. SITE STILL PUFFY, WARM TO TOUCH. PT NOT COMPLAINING OF ANY SYMPTOMS PER MOTHER.
Red, warm area developed at injection site of DTaP the day following injection.  Seen in office - consistent with sterile abscess.  No evidence for lymphangitis.  Instructed to use warm compresses and shown signs/symptoms of cellulitis.
The day following vaccination, had a severely sore arm, I was barely unable to move it. Had body aches, chills, fatigue for the whole day.
Non-pruritic maculopapular rash of skin first noted 8 hours after vaccination. Parents took patient to ED for evaluation overnight, then came in for PCP follow up 2 days later. Also had fever up to 101.
I'm a employee at Airport  on the Day of the vaccine, i had a severe headache and had to take Tylenol  and Butal-acet-caff  50-325-40 mg  and slept the whole day. The next day I woke up better but a lingering headache persists to this date.  Also, along with the headache I have nausea and light headedness the whole day. As well as dizzy spells where everything spins even if I am sitting down.  Dr.   prescribed  methylprednisolone 4 mg dose pack. Can I take this medication or what can I take because it's not getting any better
Information has been received from a licensed practical nurse concerning a 13 month old patient who on 09-SEP-2008 was vaccinated with VARIVAX (Oka/Merck). Vaccination on the same day included MMR II, VAQTA (manufacturer unknown) and PREVNAR. The licensed practical nurse reported a child presented with chicken pox lesions. The licensed nurse stated there were lesions on the child's body and face "but has already been vaccinated with VARIVAX (MSD) and the baby seems happy". At the time of reporting the patient had not recovered. Medical attention was sought: the physician was contacted. There was no product quality complaint. Follow-up received from an office manager indicated that the practice does not have any further information to report.
pt went to er (shot 6/6, er visit 6/15), diagnosed with right radial nerve palsey. no cause was given, pt just reporting. symptoms on right arm, shot given on left arm. pt claims no other reasoning. these are her assumptions.
This last weekend, 01/16/2021 I woke to a sore arm below the injection site in my left arm. As the day went on, the area started getting hot and itchy, and has lasted through today. It is not as red, or sore, but still is itchy. I have been applying Cortizone-10 to the area and has helped, and also took an allergy pill. The area affected is the muscle and skin in the bicep area.
Hives  appeared on both inner forearms, stomach, bilateral upper legs; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 67-years-old female (non pregnant) patient received bnt162b2 (BNT162B2, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 08:15 (Batch/Lot Number was EL9262) as single dose (at the age of 67-years-old) for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had not known allergies. Medical history included hypertension. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm right on 30Jan2021 08:30 AM (Batch/Lot Number was EL99265) as single dose for covid-19 immunisation. Concomitant medications (other medications in two weeks) included atenolol and chlorthalidone taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. On 21Feb2021 00:30, the patient experienced hives appeared on both inner forearms, stomach, bilateral upper legs. Patient stated that at 67 years of age, this was her first experience with hives. Therapeutic measures were taken a Benadryl cream for hives appeared on both inner forearms, stomach, bilateral upper legs. The outcome of event was recovered on an unspecified date in 2021..
vein engorgement - arms, hands, legs, feet, chest; nose bleeds, calf pain; elevated blood pressure; bruising
This spontaneous report as received from a certified medical assistant refers to a pediatric patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with VAQTA, 0.5 ml, intramuscular; third dose (lot number not reported). Concomitant medication was not reported. No adverse effect reported. This is one of several reports from the same source (1407USA011905, 1407USA011906, 1407USA011907, 1407USA011908, 1407USA011909, 1407USA011910, 1407USA011911). Additional information has been requested.
Received flu vaccine at 9:00 AM on 9-22-11. At 9:15 am she developed symptoms (nausea, vomiting, chest tightness, palpitations). Went to ED about 11:20 am for evaluation.
Patient has been sick for several months since his vaccines. Patient died 8 months later on 12/03/2021.
Information has been received from a registered nurse, who heard this from another nurse, concerning a patient who on an unspecified date, several years ago, was vaccinated with the second dose of PNEUMOVAX 23 (lot number not provided). The nurse reported that on an unspecified date the patient complained of swollen and soreness at the injection site after receiving the second dose of of vaccination 2 years apart. It was unknown if lab diagnostic studies were performed. The patient recovered from the symptoms with TYLENOL and compress treatment. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. The medical assistant reported that on multiple unspecified dates these patients were administered with PNEUMOVAX 23 single-dose vials (dose, route not reported, lot # J011045 with expiration date 15-MAY-2015, lot # K006681 with expiration date 21-OCT-2015) that were exposed to a supported temperature excursion of 32F for 8 hours on six different occasions. The medical assistant stated that these vaccines were not exposed to temperatures below 32F. No adverse effect was reported. This is one of two reports received from the same reporter (other linked MARRS# 1505USA001342). Additional information has been requested.
Vertigo/dizziness - presenting two weeks after vaccine and continues to be ongoing; tremors, internal and external - ongoing;  swollen lymph nodes under arms - immediately following vaccine and again two weeks after.
patient started experiencing redness/ itching after a week which has gotten better over time. however swelling is getting worse.
Ran a temp of 100.1 the evening after injection and the morning after injection, was aching and tired.
COLD SWEATS LEADING TO SOAKING WET; ACHES; HIGH FEVER; CHILLS; This spontaneous report received from a consumer concerned a White (Not Hispanic/Latino)  female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and  expiry: 13-MAR-2021) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced cold sweats leading to soaking wet. On 14-MAR-2021, the subject experienced aches. On 14-MAR-2021, the subject experienced high fever. On 14-MAR-2021, the subject experienced chills. Laboratory data included: Body temperature (NR: not provided) HIGH. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high fever, chills, aches, and cold sweats leading to soaking wet. This report was non-serious.
Patient experienced the expected side effects of the vaccine (arm soreness and fever) initially after vaccine administration. Two weeks later the patient reports a sore developed on the roof of her mouth as well as tingling pain in her back. The mouth sore was treated with oral nystatin 100,000 unit suspension prescribed by MD. Currently the symptoms have resolved.
A good portion of the vaccine ran on arm; A good portion of the vaccine ran on arm; The needle and the syringe separated; A spontaneous report was received from a nurse concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, the needle and the syringe separated and a good portion of the vaccine on arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 29 Dec 2020, during vaccine administration, the needle and syringe separated and a good portion the vaccine ran down the patient's arm. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The events, the needle and the syringe separated and a good portion of the vaccine ran on arm, were considered resolved on 29 Dec 2020.; Reporter's Comments: This report refers to a case of out of incorrect dose administered, exposure via skin contact and device connection issue for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of incorrect dose administered, exposure via skin contact and device connection issue.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. Medical history and drug reactions or allergies were not specified. On 30-SEP-2014, also reported as yesterday, the patient was vaccinated with an improperly stored dose of ZOSTAVAX, 0.65 ml, subcutaneously (lot number and anatomical location were not reported). No adverse effects were reported. Concomitant medications were not specified. Additional information is not expected because consent for contact was not obtained.
Pt started vomiting 3/18/02. non stop every time he drank fluids. Diarrhea X 5, fever 101,. 3/19/02: still vomiting fluids pediate and breast milk. tylemo and dimetapp3/19 temperature 88. nurse referred child to PMD